These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1209626)

  • 41. Transformation of delta-1-tetrahydrocannabinol (THC) by rabbit liver microsomes.
    Ben-Zvi Z; Burstein S
    Biochem Pharmacol; 1975 May; 24(10):1130-1. PubMed ID: 1156437
    [No Abstract]   [Full Text] [Related]  

  • 42. An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant.
    Cradock JC; Davignon JP; Litterst CL; Guarino AM
    J Pharm Pharmacol; 1973 Apr; 25(4):345. PubMed ID: 4146694
    [No Abstract]   [Full Text] [Related]  

  • 43. Distribution of DF32P in mouse organs. I. The effect of route of administration of incorporation and toxicity.
    Ramachandran BV
    Biochem Pharmacol; 1966 Feb; 15(2):169-75. PubMed ID: 5947196
    [No Abstract]   [Full Text] [Related]  

  • 44. Systemic absorption of delta 9-tetrahydrocannabinol after ophthalmic administration to the rabbit.
    Chiang CW; Barnett G; Brine D
    J Pharm Sci; 1983 Feb; 72(2):136-8. PubMed ID: 6300368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 46. Distribution of tritium labelled delta 1-tetrahydrocannabinol in the rat brain following intraperitoneal administration.
    Layman JM; Milton AS
    Br J Pharmacol; 1971 Jun; 42(2):308-10. PubMed ID: 5091165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol.
    Dewey WL; McMillan DE; Harris LS; Turk RF
    Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135
    [No Abstract]   [Full Text] [Related]  

  • 48. Metabolism and autoradiographic distribution of delta-8- and delta-9-tetrahydrocannabinol in some organs of the monkey Callithrix jacchus.
    Just WW; Erdmann G; Thel S; Werner G; Wiechmann M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):219-25. PubMed ID: 806815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of phenobarbital and SKF 525A pretreatment, sex, liver injury, and vehicle on delta9-tetrahydrocannabinol toxicity.
    Mantilla-Plata B; Harbison RD
    Toxicol Appl Pharmacol; 1974 Jan; 27(1):123-30. PubMed ID: 4851768
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 51. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of various psychoative drugs on the metabolism of delta-tetrahydrocannabinol by rats in vitro and in vivo.
    Siemens AJ; De Nie LC; Kalant H; Khanna JM
    Eur J Pharmacol; 1975 Mar; 31(1):136-47. PubMed ID: 1126372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
    Levy S; McCallum NK
    Experientia; 1975 Nov; 31(11):1268-9. PubMed ID: 1204768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.
    Hollister LE
    Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598
    [No Abstract]   [Full Text] [Related]  

  • 55. [Toxicity of Indian hemp].
    Nahas GG; Vourch G
    Nouv Presse Med; 1973 Jan; 2(3):167-73. PubMed ID: 4685021
    [No Abstract]   [Full Text] [Related]  

  • 56. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracellular distribution of 3h-delta8-tetrahydrocannabinol in rat organs after I.V. administration.
    Jakubovic A; McGeer PL
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):197-200. PubMed ID: 4438825
    [No Abstract]   [Full Text] [Related]  

  • 58. Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.
    Widman M; Agurell S; Ehrnebo M; Jones G
    J Pharm Pharmacol; 1974 Nov; 26(11):914-6. PubMed ID: 4156569
    [No Abstract]   [Full Text] [Related]  

  • 59. The uptake of tritiated delta 1-tetrahydrocannabinol by the isolated vas deferens of the rat.
    Egan SM; Graham JD; Lewis MJ
    Br J Pharmacol; 1976 Apr; 56(4):413-6. PubMed ID: 1260220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative autoradiographic and metabolic study of delta8- and delta9-tetrahydrocannabinol in the brain of the marmoset Callithrix jacchus.
    Erdmann G; Just WW; Thel S; Werner G; Wiechmann M
    Psychopharmacology (Berl); 1976 May; 47(1):53-8. PubMed ID: 822439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.